Aoxing Pharmaceutical Company, Inc.
AOXGOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$320107
P/E Ratio—
52W High$0.0107
52W Low$0.0016
Aoxing Pharmaceutical Company, Inc. (AOXG) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · AOXG · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-06 | 2024-06 |
|---|---|---|
| Revenue | ||
| Revenue | $0.00B | $0.00B |
| Cost of Revenue | $0.00B | $0.00B |
| Gross Profit | $0.00B | $0.00B |
| Gross Margin %(computed) | — | — |
| Operating Expenses | ||
| R&D Expenses | $0.00B | $0.00B |
| G&A Expenses | $0.00B | $0.00B |
| Total Operating Expenses | $0.00B | $0.00B |
| Operating Income | ($0.00B) | ($0.00B) |
| Operating Margin %(computed) | — | — |
| Interest Income | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B |
| Income Before Tax | $0.00B | ($0.00B) |
| Income Tax Expense | $0.00B | $0.00B |
| Net Income | $0.00B | ($0.00B) |
| Net Margin %(computed) | — | — |
| Per Share & EBITDA | ||
| EPS (Basic) | $0.00 | $-0.00 |
| Wtd Avg Shares | 0.38B | 0.34B |
| EBITDA | $0.00B | ($0.00B) |
| EBITDA Margin %(computed) | — | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · B
Explore more Aoxing Pharmaceutical Company, Inc. data
About Aoxing Pharmaceutical Company, Inc. (AOXG) Income Statement
Aoxing Pharmaceutical Company, Inc. (AOXG) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, AOXG reported revenue of $0.00B, gross profit of $0.00B (gross margin —), and net income of $0.00B — a net profit margin of —.
Frequently asked questions
AOXG · 4 questionsAoxing Pharmaceutical Company, Inc. (AOXG) reported revenue of $0.00B for 2025, down —% year-over-year.
AOXG revenueAOXG salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09